Kalaris Therapeutics, Inc. KLRS
1.58 USD -0.08 (-5.12%)
Regular-session close
1.56 -0.01 -0.90%
After hours · Nov 13, 4:00 PM ET
1.55 Day range 1.70
1.58 52-week range 10.98
- YTD
- -81.34%
- 1 year
- -70.45%
- Market cap
- 37.49M
- EPS (ttm)
- -1.84
- YTD return
- -81.34%
- 1-year return
- -70.45%
- Volume
- 41.00K
- Avg volume
- 73.19K
- Open
- 1.64
- Previous close
- 1.66
- Day's range
- 1.55 – 1.70
- 52-week range
- 1.58 – 10.98
No chart data for this range yet.
Financials — quick view
KLRS Revenue — quarterly 0
KLRS Net income — quarterly -11.03M
KLRS EPS — quarterly -0.46
News
Citizens Maintains Market Outperform on Kalaris Therapeutics, Lowers Price Target to $20 
Kalaris Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate 
Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update 
Alpha Buying: 3 Beaten-Down Biotech Stocks Backed by a Specialist Investor 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
Kalaris Therapeutics Q2 EPS $(0.48) Beats $(0.49) Estimate - Kalaris Therapeutics Appoints Liisa Bayko CFO
Why Is Kalaris Therapeutics Stock Gaining Friday? 
12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on KLRS — it syncs with the Stock Master app.